YANG Feng, XU Jia, QIU Guo-hui, YANG Zhi-ling*
|  Kim SH, Song MK, Joung JY, et al. Significant clinicopathologic prognostic factors for bladder recurrence, progression, and cancer-specific survival after surgery among patients with upper urinary tract urothelial carcinoma[J]. Investig Clin Urol, 2019, 60: 432-442.
 Lu CS, Shieh GS, Wang CT, et al. Chemotherapeutics-induced Oct4 expression contributes to drug resistance and tumor recurrence in bladder cancer[J]. Oncotarget, 2017, 8: 30844-30858.
 Wang LH, Shang L, Shan DY, et al. Long-term floating control-released intravesical preparation of 5-fluorouracil for the local treatment of bladder cancer[J]. Drug Dev Ind Pharm, 2017, 43: 1343-1350.
 Rupaimoole R, Slack FJ. microRNA therapeutics: towards a new era for the management of cancer and other diseases[J]. Nat Rev Drug Discov, 2017, 16: 203-222.
 Sun R, Liu Z, Tong D, et al. miR-491-5p, mediated by Foxi1, functions as a tumor suppressor by targeting Wnt3a/β-catenin signaling in the development of gastric cancer[J]. Cell Death Dis, 2017, 8: e2714. doi:10.1038/cddis.2017.134.
 Zhang J, Raju GS, Chang DW, et al. Global and targeted circulating microRNA profiling of colorectaladenoma and colorectal cancer[J]. Cancer, 2018, 124: 785-796.
 Zhang Y, Xu W, Ni P, et al. miR-99a and miR-491 regulate cisplatin resistance in human gastric cancer cells by targeting CAPNS1[J]. Int J Biol Sci, 2016, 12: 1437-1447.
 Wang SN, Luo S, Liu C, et al. miR-491 inhibits osteosarcoma lung metastasis and chemoresistance by targeting αB-crystallin[J]. Mol Ther, 2017, 25: 2140-2149.
 刘进生,黄良祥,李建党,等. miR-140-5p调控Nrf2影响结肠癌细胞5-FU耐药性[J]. 中国癌症防治杂志, 2018, 10: 193-198.
 Chen Y, Lian G, Ou G, et al. Inverse association between Bmi-1 and RKIP affecting clinical outcome of gastric cancer and revealing the potential molecular mechanisms underlying tumor metastasis and chemotherapy resistance[J]. Gastric Cancer, 2016, 19: 392-402.
 Galletti G, Leach BI, Lam L, et al. Mechanisms of resistance to systemic therapy in metastatic castration-resistant prostate cancer[J]. Cancer Treat Rev, 2017, 57: 16-27.
 Wang H, Luo Y, Qiao T, et al. Luteolin sensitizes the antitumor effect of cisplatin in drug-resistant ovarian cancer via induction of apoptosis and inhibition of cell migration and invasion[J]. J Ovarian Res, 2018, 11: 93. doi: 10.1186/s13048-018-0468-y.
 Zhou H, Huang HY, Shapiro E, et al. Urothelial tumor initiation requires deregulation of multiple signaling pathways: implications in target-based therapies[J]. Carcinogenesis, 2012, 33: 770-780.
 Anand V, Khandelwal M, Appunni S, et al. CD44 splice variant (CD44v3) promotes progression of urothelial carcinoma of bladderthrough Akt/ERK/STAT3 pathways: novel therapeutic approach[J]. J Cancer Res Clin Oncol, 2019, 145: 2649-2661.
|||BAI Bing, ZHANG Hai-fang, YANG Qing-liang, QIN Yue, ZHOU Chen-long, SONG Ge, WANG Ying. Down-regulation of lncRNA RHPN1-AS1 inhibits proliferation and migration of human bladder cancer cell line T24 [J]. Basic & Clinical Medicine, 2022, 42(6): 940-944.|
|||YANG Mang-zhuang, YANG Xu-dong, WANG Xiao-long. Circ-MALAT1 targeting miR-101 inhibits invasion and migration of bladder cancer cell line SW780 [J]. Basic & Clinical Medicine, 2022, 42(3): 472-478.|
|||LIANG Bing, LUO Hou-zhou. Therapeutic effect and mechanism of celecoxib on bladder cancer cell implanted mice [J]. Basic & Clinical Medicine, 2021, 41(2): 240-244.|
|||LI Hong-ming, YU Lang, LI Rui, SHEN Jie, ZHANG Fu-quan, WU Song. Comparison of dosimetry between TOMO and VMAT after TURBT for bladder cancer [J]. Basic & Clinical Medicine, 2020, 40(11): 1529-1533.|
|||. Inhibitory effect and mechanism of 5-FU in TGF-β1-induced human intrahepatic biliary epithelial - mesenchymal transition [J]. Basic & Clinical Medicine, 2017, 37(8): 1122-1127.|
|||. miR-130b-3p may serve as a marker for human bladder cancer [J]. Basic & Clinical Medicine, 2017, 37(12): 1691-1698.|
|||. The efficacy of modified docetaxel, cisplatin and 5-fluorouracil combination chemotherapy in advanced gastric cancer [J]. Basic & Clinical Medicine, 2012, 32(12): 1456-1460.|
|||. Sunitinb Inhibits the proliferation of human bladder cancer line T24 in vitro [J]. Basic & Clinical Medicine, 2011, 31(9): 988-990.|
|||Yi-bing ZHANG; Hai-tao NIU; Ji-wu CHANG. Analysis of differential expression gene profiles of bladder cancer EJ cell line characterized by downregulation of EZH2 gene [J]. Basic & Clinical Medicine, 2008, 28(12): 1243-1247.|